Article Versions Notes

Sánchez-Sánchez M-P, Martín-Illana A, Ruiz-Caro R, Bermejo P, Abad M-J, Carro R, Bedoya L-M, Tamayo A, Rubio J, Fernández-Ferreiro A, et al. Chitosan and Kappa-Carrageenan Vaginal Acyclovir Formulations for Prevention of Genital Herpes. In Vitro and Ex Vivo Evaluation. Marine Drugs. 2015; 13(9):5976-5992. https://doi.org/10.3390/md13095976

Sánchez-Sánchez, María-Pilar, Araceli Martín-Illana, Roberto Ruiz-Caro, Paulina Bermejo, María-José Abad, Rubén Carro, Luis-Miguel Bedoya, Aitana Tamayo, Juan Rubio, Anxo Fernández-Ferreiro, and et al. 2015. "Chitosan and Kappa-Carrageenan Vaginal Acyclovir Formulations for Prevention of Genital Herpes. In Vitro and Ex Vivo Evaluation" Marine Drugs 13, no. 9: 5976-5992. https://doi.org/10.3390/md13095976

Sánchez-Sánchez, M. -P., Martín-Illana, A., Ruiz-Caro, R., Bermejo, P., Abad, M. -J., Carro, R., Bedoya, L. -M., Tamayo, A., Rubio, J., Fernández-Ferreiro, A., Otero-Espinar, F., & Veiga, M. -D. (2015). Chitosan and Kappa-Carrageenan Vaginal Acyclovir Formulations for Prevention of Genital Herpes. In Vitro and Ex Vivo Evaluation. Marine Drugs, 13(9), 5976-5992. https://doi.org/10.3390/md13095976